MGTX

MeiraGTx Holdings plc

There isn't enough reported data to score MGTX yet.

MGTX Fundamentals

MetricStatus
Unavailable
Strong
Under pressure
Strong

MGTX's profitability and balance sheet are currently strong, but its cash flow is under pressure. There isn't enough data to rate its revenue.

MGTX PE Valuation

LevelPEPriceVs current
Current11x$8.79โ€”
Cheap13x$10.39+18%
Fair15x$12.22+39%
Expensive19x$15.50+76%

Historical ranges are pointers, not guarantees.

MGTX's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.

MGTX Forward outlook

MetricOutlook
--
Losses steady
Strong growth
--
Limited
Low

Analysts expect MGTX's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.

MGTX Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $8.79 on Nov 12.

There is not enough scenario data to assess MGTX's risk to reward.

MGTX Earnings Per Share

Q4 2023: $-1.49Q1 2024: $-1.19Q2 2024: $-1.42Q3 2024: $-1.23Q4 2024: $-2.12Q1 2025: $-2.31Q2 2025: $-2.03Q3 2025: $-2.10Q4 2025: $-1.42Q1 2026: $-1.48Q2 2026: $0.71Q3 2026: $0.80
Q4 2023: $-1.49Q1 2024: $-1.19Q2 2024: $-1.42Q3 2024: $-1.23Q4 2024: $-2.12Q1 2025: $-2.31Q2 2025: $-2.03Q3 2025: $-2.10Q4 2025: $-1.42Q1 2026: $-1.48Q2 2026: $0.71Q3 2026: $0.80
QuarterTTM EPSYoY
Q3 2026$0.80+$2.90
Q2 2026$0.71+$2.74
Q1 2026-$1.48+$0.83
Q4 2025-$1.42+$0.70
Q3 2025-$2.10-$0.87
Q2 2025-$2.03-$0.61
Q1 2025-$2.31-$1.12
Q4 2024-$2.12-$0.63

MGTX has returned to profit: it earned $0.80 per share over the past year, after losing money the year before.

MGTX Quarterly Revenue

Q4 2023: --Q1 2024: $697,000Q2 2024: $282,000Q3 2024: $11MQ4 2024: $21MQ1 2025: --Q2 2025: $4MQ3 2025: $410,000Q4 2025: $75MQ1 2026: $293,000Q2 2026: $321MQ3 2026: $5M
Q4 2023: --Q1 2024: $697,000Q2 2024: $282,000Q3 2024: $11MQ4 2024: $21MQ1 2025: --Q2 2025: $4MQ3 2025: $410,000Q4 2025: $75MQ1 2026: $293,000Q2 2026: $321MQ3 2026: $5M
QuarterRevenueYoY
Q3 2026$4.8M+1074%
Q2 2026$321.4M+8609%
Q4 2025$75.4M+252%
Q3 2025$410K-96%
Q2 2025$3.7M+1209%
Q3 2024$10.9M+114%
Q2 2024$282K-92%
Q1 2024$697K-79%

MGTX's revenue is growing: $5M last quarter, up 1074% from the same quarter a year ago.

MGTX Free Cash Flow

Q4 2023: โˆ’$18MQ1 2024: โˆ’$38MQ2 2024: โˆ’$21MQ3 2024: โˆ’$26MQ4 2024: โˆ’$24MQ1 2025: โˆ’$39MQ2 2025: โˆ’$45MQ3 2025: โˆ’$13MQ4 2025: $46MQ1 2026: $16MQ2 2026: โˆ’$39MQ3 2026: โˆ’$26M
Q4 2023: โˆ’$18MQ1 2024: โˆ’$38MQ2 2024: โˆ’$21MQ3 2024: โˆ’$26MQ4 2024: โˆ’$24MQ1 2025: โˆ’$39MQ2 2025: โˆ’$45MQ3 2025: โˆ’$13MQ4 2025: $46MQ1 2026: $16MQ2 2026: โˆ’$39MQ3 2026: โˆ’$26M
QuarterFree cash flowYoY
Q3 2026-$26.3M-$13.5M
Q2 2026-$38.9M+$6.3M
Q1 2026$15.8M+$54.3M
Q4 2025$46.4M+$70.9M
Q3 2025-$12.8M+$12.9M
Q2 2025-$45.2M-$24.4M
Q1 2025-$38.5M-$119K
Q4 2024-$24.5M-$6.9M

MGTX has burned cash in almost every quarter: โˆ’$3M over the past year, against โˆ’$121M the year before.

MGTX Total Shares

Q4 2023: 56MQ1 2024: 64MQ2 2024: 64MQ3 2024: 72MQ4 2024: 70MQ1 2025: 79MQ2 2025: 81MQ3 2025: 81MQ4 2025: 80MQ1 2026: 81MQ2 2026: 94MQ3 2026: 97M
Q4 2023: 56MQ1 2024: 64MQ2 2024: 64MQ3 2024: 72MQ4 2024: 70MQ1 2025: 79MQ2 2025: 81MQ3 2025: 81MQ4 2025: 80MQ1 2026: 81MQ2 2026: 94MQ3 2026: 97M
PeriodChange %Net change
Quarterly+3.3%+3.1M shares
1 year+20%+15.9M shares
3 years+63%+37.4M shares
5 years+119%+52.7M shares
Available history+192%+63.7M shares

MGTX has 97M diluted shares, up 20% from a year ago.

MGTX Net Leverage

Q2 2026: -0.2xQ3 2026: -0.3x
Q2 2026: -0.2xQ3 2026: -0.3x
QuarterNet LeverageStatus
Q3 2026-0.3xNet Cash
Q2 2026-0.2xNet Cash

MGTX has more cash than debt.

MGTX Weekly Momentum

MetricValueStatus
RSI38.5Neutral
Stochastic6.8Oversold

MGTX's weekly RSI is 38 (neutral) and its Stochastic is 7 (oversold).

MGTX PE vs Healthcare Sector

MetricMGTXSector medianRelative
PE11x26x57% below

MGTX is trading at 11x earnings, a 57% discount to the Healthcare sector's median of 26x, though its earnings don't support one.

MGTX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$9.7710% below
20 week MA$11.826% below
50 week MA$9.9011% below
100 week MA$8.493.5% above
200 week MA$7.1124% above

MGTX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.

MGTX Yearly ROI

YearStart priceEnd priceROI
2020$20.1$16.4-18%
2021$16.4$22.4+36%
2022$22.4$6.01-73%
2023$6.01$7.02+17%
2024$7.02$6.21-12%
2025$6.21$7.97+28%
2026 YTD$7.97$8.79+10%

MGTX has finished lower in three of the last six years. It's up 10% so far in 2026.

Give your agent the market.

Get API key